Skip Navigation



Rheumatology Advance Access published online on October 27, 2004
Rheumatology, doi:10.1093/rheumatology/keh446
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/2/151    most recent
keh446v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Edwards, J. C. W.
Right arrow Articles by Cambridge, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, J. C. W.
Right arrow Articles by Cambridge, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received June 14, 2004
Accepted September 21, 2004

Review

Prospects for B-cell-targeted therapy in autoimmune disease

J. C. W. Edwards 1* and G. Cambridge 1

1 University College London Centre for Rheumatology, London, UK



This article has no Abstract. Keywords: Rituximab; B-cell depletion; Autoimmunity; Rheumatoid arthritis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
R. H. Shmerling
Testing for Anti-Cyclic Citrullinated Peptide Antibodies: Is It Time to Set This Genie Free?
Arch Intern Med, January 12, 2009; 169(1): 9 - 14.
[Full Text] [PDF]

Home page
 NeurologyHome page
M. C. Dalakas
Invited Article: Inhibition of B cell functions: Implications for neurology
Neurology, June 3, 2008; 70(23): 2252 - 2260.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
I. Nestorov, A. Munafo, O. Papasouliotis, and J. Visich
Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis
J. Clin. Pharmacol., April 1, 2008; 48(4): 406 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J.-D. Bouaziz, K. Yanaba, G. M. Venturi, Y. Wang, R. M. Tisch, J. C. Poe, and T. F. Tedder
Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice
PNAS, December 26, 2007; 104(52): 20878 - 20883.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Hasegawa, Y. Hamaguchi, K. Yanaba, J.-D. Bouaziz, J. Uchida, M. Fujimoto, T. Matsushita, Y. Matsushita, M. Horikawa, K. Komura, et al.
B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic Sclerosis
Am. J. Pathol., September 1, 2006; 169(3): 954 - 966.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
O. M. R. Westwood, P. N. Nelson, and F. C. Hay
Rheumatoid factors: what's new?
Rheumatology, April 1, 2006; 45(4): 379 - 385.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Kastbom, A. Ahmadi, P. Soderkvist, and T. Skogh
The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project)
Rheumatology, October 1, 2005; 44(10): 1294 - 1298.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. Watts, L. Harper, D. Jayne, J. Levy, C. Pusey, C. Savage, D. G. I. Scott, and J. Williams
Translational research in autoimmunity: aims of therapy in vasculitis
Rheumatology, May 1, 2005; 44(5): 573 - 576.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.